Prostate cancer is the second most common cancer in the U.S. There were more than 200,000 new cases of prostate cancer in 2017, the latest year with available data from the CDC. The incidence of surgery for prostate cancer has dropped during the past decade, from nearly half (47%) in 2010, according to WebMD, to less than a third (31%) in 2015. Approximately 10% of men who have prostate cancer surgery suffer from Persistent UI, defined as urinary incontinence after one year following surgery.
Vancouver, BC-based MedTech Ltd, recently announced the Pacey Cuff Guard, a supplementary device used with the company’s Pacey Cuff Turbo, a urethral control device (UCD) that helps treat incontinence. The Pacey Cuff Turbo is a cushioned clamp that allows blood flow while it restricts urine flow through the urethra. The Pacey Cuff Guard is an incontinence pad that works with the Cuff as a backup device to catch any urine that escapes when the Cuff is in place.
The Cuff guard is made of washable and reusable adsorbent neoprene that fits comfortably and discretely in conventional men’s underwear, according to a company news release. MedTech designed the Pacey Cuff Turbo and Pacey Cuff Guard to be used in conjunction. The goal is for men with Persistent UI to live comfortable, more normal lives with less concern about leaks, odors, or embarrassment.
